A Five-Plasma Protein–Based Algorithm for Predicting Incident CKD in Type 2 Diabetes
Journal of the American Society of Nephrology · 2026
DOI: 10.1681/asn.0000000902 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Society of Nephrology, 2026. Verfasst von Chenxin Xu und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Pharmaceutical Biotechnology, University of Hong Kong, Hong Kong, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Renal Insufficiency, Chronic, Blood Proteins, Diabetic Nephropathies. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Key R&D Program of China, Shenzhen-Hong Kong-Macau Science and Technology Program, Hong Kong Research Grants Council/Area of Excellence.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Key Points Proteomics analyses consistently identified nine independent protein predictors for CKD in both Chinese and European participants with type 2 diabetes. A novel prediction model, “eGFR+five-protein panel predicting CKD,” reliably predicted CKD with good performance (area under the receiver operating characteristic curve ≥0.80). The new “eGFR+five-protein panel predicting CKD” model exhibited superior performance over traditional clinical models.
Background
Currently, there is a lack of reliable biomarkers for noninvasive prediction of CKD in patients with diabetes. This study aimed to identify novel protein predictors and construct a prediction model for incident CKD in participants with type 2 diabetes applicable across different populations.
Methods
A targeted Olink plasma proteomics profiling analysis, involving 368 proteins, was conducted in a nested case-control study comprising 132 incident CKD cases and 132 non-CKD controls, matched for age, sex, duration of diabetes, and eGFR, recruited from a long-term prospective cohort of Chinese type 2 diabetes participants (median approximately 9-year follow-up). False discovery rate was applied for multiple testing corrections. A q -value
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Pharmaceutical Biotechnology, University of Hong Kong, Hong Kong, China.
- Department of Medicine, School of Clinical Medicine, University of Hong Kong, Hong Kong, China.
- Guangdong-Hong Kong Joint Institute for Metabolic Medicine, University of Hong Kong, Hong Kong, China.
ORCID-Profile: Chenxin Xu, Junda Zhong, David Tak-Wai Lui
Förderung
- National Key R&D Program of China
- Shenzhen-Hong Kong-Macau Science and Technology Program
- Hong Kong Research Grants Council/Area of Excellence
- National Natural Science Foundation of China (NSFC) grants
- Health and Medical Research Fund (HMRF)
Zitieren
APA
Xu, C., Cheung, C. Y., Zhong, J., Lin, Y., Fong, C. H., Jiang, X., Jia, X., Lui, D. T., Lee, C. H., Lam, K. S., & Xu, A. (2026). A Five-Plasma Protein–Based Algorithm for Predicting Incident CKD in Type 2 Diabetes. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.0000000902
Vancouver
Xu C, Cheung CY, Zhong J, Lin Y, Fong CH, Jiang X, et al. A Five-Plasma Protein–Based Algorithm for Predicting Incident CKD in Type 2 Diabetes. Journal of the American Society of Nephrology. 2026. doi:10.1681/asn.0000000902
BibTeX
@article{Xu2026,
author = {Xu, Chenxin and Cheung, Chloe Yu-Yan and Zhong, Junda and Lin, Yifen and Fong, Carol Ho-Yi and Jiang, Xue and Jia, Xi and Lui, David Tak-Wai and Lee, Chi-Ho and Lam, Karen Siu-Ling and Xu, Aimin},
title = {A Five-Plasma Protein–Based Algorithm for Predicting Incident CKD in Type 2 Diabetes},
journal = {Journal of the American Society of Nephrology},
year = {2026},
doi = {10.1681/asn.0000000902}
}
EUVIMED